Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 20,371,900 | 18,633,500 | 15,691,000 | 14,645,300 | 13,857,900 |
| Cost of Goods | 4,376,700 | 4,248,800 | 3,546,500 | 3,474,200 | 3,223,900 |
| Gross Profit | 15,995,200 | 14,384,700 | 12,144,500 | 11,171,100 | 10,634,000 |
| Operating Expenses | 15,303,400 | 10,328,200 | 8,019,600 | 7,522,700 | 7,368,400 |
| Operating Income | 692,500 | 4,057,301 | 4,125,400 | 3,648,600 | 3,266,500 |
| Other Income | -2,000,100 | -180,501 | -707,400 | -931,100 | -324,600 |
| Pre-tax Income | -1,307,600 | 3,876,800 | 3,418,000 | 2,717,500 | 2,941,900 |
| Income Tax | 764,300 | 923,800 | 755,300 | 715,900 | 1,131,800 |
| Net Income Continuous | -2,071,900 | 2,953,000 | 2,662,700 | 2,001,600 | 1,810,100 |
| Net Income | $-2,071,900 | $2,953,000 | $2,662,700 | $1,979,600 | $1,810,100 |
| EPS Basic Total Ops | -1.89 | 2.71 | 2.45 | 1.82 | 1.67 |
| EPS Basic Continuous Ops | -1.89 | 2.71 | 2.45 | 1.84 | 1.67 |
| EPS Diluted Total Ops | -1.89 | 2.71 | 2.45 | 1.81 | 1.66 |
| EPS Diluted Continuous Ops | -1.89 | 2.71 | 2.45 | 1.83 | 1.66 |
| EBITDA(a) | $1,815,100 | $5,105,201 | $4,927,200 | $4,375,000 | $3,864,000 |